Diffuse optical tomography (DOT) to use for breast cancer screening. Image by Clemson University.


October 7, 2009 - Mathematical solutions to enhance the image quality of diffuse optical tomography (DOT) to use for breast cancer screening is in development at Clemson University in collaboration with researchers at the University of Bremen, Germany.

The challenge with DOT is to create high-resolution images from a scattering of infrared and visible light for the early detection of breast cancer. Mathematical sciences professors Taufiquar Khan of Clemson and Peter Maass of the University of Bremen are developing mathematical models to improve resolution.

While the method is less expensive, safer and more comfortable than X-rays used in mammograms, the problem is it not generating a strong enough resolution to detect smaller breast cancers.

DOT may eliminate harmful radiation to the body as well as false positives and negatives caused by mammography X-rays. Researchers hope that the discomfort of mammograms will become a thing of the past and that DOT will enable diagnostic imaging eventually to be done in a home setting. It could also possibly be used as an adjunct to diagnostic procedures such as ultrasound.

For more information: www.clemson.edu


Related Content

News | Breast Imaging

July 7, 2026 — QT Imaging Holdings, Inc. recently announced it has successfully completed its first routine inspection ...

Time July 07, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
News | Mammography

June 30, 2026 — The Food and Drug Administration has cleared new contrast-enhanced mammography (CEM) and CEM biopsy ...

Time June 30, 2026
arrow
News | Mammography

June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...

Time June 24, 2026
arrow
News

May 21, 2026 – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 22, 2026
arrow
News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
News | Breast Imaging

April 15, 2026 — QT Imaging Holdings, Inc. has launched its QTI Imaging-Olea Viewer, developed in collaboration with ...

Time April 15, 2026
arrow
News | Breast Imaging

April 1, 2026 — QT Imaging Holdings has released its latest image reconstruction software update, version 4.5.0. This ...

Time April 02, 2026
arrow
News | Ultrasound Imaging

March 30, 2026 — Butterfly Network, Inc. has received clearance from the U.S. Food and Drug Administration (FDA) for a ...

Time April 01, 2026
arrow
News | Breast Imaging

March 30, 2026 — Each year, the Alumni Association at the University of Missouri-Kansas City, recognizes the ...

Time March 31, 2026
arrow
Subscribe Now